Peer-Reviewed Articles from Managed Care


Consumer-Directed Health Plans: Enrollee Views, Early Employer Experience

As CDHPs increasingly penetrate the commercial market , their greatest contribution might lie in funding health services for retirees and in reducing the number of uninsured people by offering affordable insurance.

Janice Frates, PhD; Ellen Severoni, RN


Clinical and Economic Effects of Coronary Restenosis After Percutaneous Coronary Intervention in a Managed Care Population

This study is the first to estimate costs and medical resource use associated with restenosis involving bare metal stents in managed care percutaneous coronary intervention patients.

Mary Ann Clark, MHA


Managing Drugs for Rare Genetic Diseases: Trends and Insights

This article evaluates recent trends and challenges in health system management of exceedingly rare genetic diseases, from the perspective of the manufacturer, managed care organization, physician, and actuary.

Mark Zitter, MBA


Measuring Outpatient Outcomes of Emesis and Nausea Management in Pregnant Women

In this study, outpatient management was effective in controlling nausea and vomiting during pregnancy and was associated with a reduced need for hospital or emergency room treatment as well as reduced costs.

David G. Lombardi, MD; Niki B. Istwan, RN; Debbie J. Rhea, MPH; John M. O'Brien, MD; John R. Barton, MD


Evaluating New Therapies for Psoriasis

Along with traditional systemic therapies, the American Academy of Dermatology recommends four biologic agents as first-line treatment for psoriasis patients who are candidates for systemic therapy.

Thomas Morrow, MD


Improving Physician Attendance At Educational Seminars Sponsored By Managed Care Organizations

Although interactive educational seminars that target physicians require a large investment of resources, they can be cost-effective if medical care is improved as a result.

Michael D. Cabana, MD, MPH<sup>1</sup>; Randall Brown, MD, MPH<sup>1</sup>; Noreen M. Clark, PhD<sup>2</sup>; Diane F. White, RRT<sup>1</sup>; Juanita Lyons, PhD<sup>1</sup>; Sylvia Wanner Lang, PhD<sup>1</sup>; Susan L. Bratton, MD, MPH<sup>1</sup>


Cost-effective Management of Hyperglycemia in Patients With Type 2 Diabetes Using Oral Agents

Sulfonylureas are cost-effective and also may be the only oral agents that inhibit processes inducing hyperglycemia by improving insulin secretion and insulin resistance. New long-acting agents hold even greater promise.

Udaya M. Kabadi, MD


Advances in Migraine Management: Implications for Managed Care Organizations

In response to the expense of new migraine therapies, treatment practices aimed at controlling direct costs are now the norm.

David W. Dodick, MD; Robert J. Lipsy, PharmD


IgE-Blocking Therapy for Difficult-to-Treat Asthma: A Brief Review

Omalizumab, a novel therapy that targets specific steps in the inflammatory cascade of asthma, may benefit the hard-to-treat patient.

Gailen D. Marshall Jr., MD, PhD


Improving Oral Pharmacologic Treatment And Management of Type 2 Diabetes

New oral treatment options and outcome measures may help patients with type 2 diabetes to achieve better results while reducing associated costs.

George E. Dailey III, MD

more